Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-β1 expression

Oncogene

Volumn 24, Issue 4, 2005, Pages 552-560

  Boulanger, Corinne A ^a   Wagner, Kay Uwe ^b   Smith, Gilbert H ^a,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c Bldg 10   (United States)

Author keywords

Cell fate; Mammary; Pregnancy; Stem cells; TGF 1; Transplantation

Indexed keywords

ACID PROTEIN; BETA GALACTOSIDASE; CRE RECOMBINASE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; WHEY ACIDIC PROTEIN PROMOTER;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER RISK; CELL AGING; CELL PROLIFERATION; CELL RENEWAL; CELL TRANSPLANTATION; FEMALE; INVOLUTION; LACTATION; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; MULTIPLE PREGNANCY; MYOEPITHELIUM CELL; NONHUMAN; PARITY; PARITY INDUCED MAMMARY EPITHELIAL CELL; PLURIPOTENT STEM CELL; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSPLANTATION;

ANIMALS; CELL LINEAGE; CELL PROLIFERATION; CELL TRANSPLANTATION; CELLS, CULTURED; EPITHELIAL CELLS; FEMALE; INTEGRASES; LAC OPERON; MALE; MAMMARY GLANDS, ANIMAL; MICE; MICE, TRANSGENIC; MILK PROTEINS; PARITY; PLURIPOTENT STEM CELLS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VIRAL PROTEINS;

ANIMALIA; MOUSE MAMMARY TUMOR VIRUS; MURINAE; ONCOVIRINAE;

EID: 13244273440     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208185     Document Type: Article

References (19)

1. Boulanger CA and Smith GH. (2001). Oncogene, 20, 2264-2272.
2. Callahan R and Smith GH. (2000). Oncogene, 19, 992-1001.
3. Daniel C, DeOme K, Young L, Blair P and Faulkin L. (1968). Proc. Natl. Acad. Sci. USA, 61, 53-60.
4. DeOme KB, Fauklin LJ, Bern HA and Blair PB. (1959). J. Natl. Cancer Inst., 78, 751-757.
5. DeOme KB, Miyamoto MJ, Osborn RC, Guzman RC and Lum K. (1978). Cancer Res., 38, 2103-2111.
6. Henry MD, Triplett AA, Oh KB, Smith GH and Wagner K-U. (2004). Oncogene, 23, 6980-6985.
7. Jhappan C, Geiser AG, Kordon EC, Bagheri D, Hennighausen L, Roberts AB, Smith GH and Merlino G. (1993). EMBO J., 12, 1835-1845.
8. Kordon EC, McKnight RA, Jhappan C, Hennighausen L, Merlino G and Smith GH. (1995). Dev. Biol., 168, 47-61.
9. Kordon EC and Smith GH. (1998). Development, 125, 1921-1930.
10. Lin H. (2002). Nat. Rev. Genet., 3, 931-939.
11. Robinson GW, McKnight RA, Smith GH and Hennighausen L. (1995). Development, 121, 2079-2090.
12. Robinson GW, Smith GH, Gallahan D, Zimmer A, Furth PA and Hennighausen L. (1996). Dev. Dynam., 206, 159-168.
13. Sivaraman L, Conneely OM, Medina D and O'Malley BW. (2001). Proc. Natl. Acad. Sci. USA, 98, 12379-12384.
14. Sivaraman L, Stephens LC, Markaverich BM, Clark JA, Krnacik S, Conneely OM, O'Malley BW and Medina D. (1998). Carcinogenesis, 19, 1573-1581.
15. Smith G, Gallahan D, Zweibel J, Freeman S, Bassin R and Callahan R. (1991). J. Virol., 65, 6365-6370.
16. Smith GH. (1996). Breast Cancer Res. Treat., 39, 21-31.
17. Wagner K-U, Boulanger CA, Henry MD, Sagagias M, Hennighausen L and Smith GH. (2002). Development, 129, 1377-1386.
18. Wagner KU, Wall RJ, St-Onge L, Gruss P, Wynshaw-Boris A, Garrett L, Li M, Furth PA and Hennighausen L. (1997). Nucleic. Acids Res., 25, 4323-4330.
19. Williams JM and Daniel CW. (1983). Dev. Biol., 97, 274-290.